Now back for a third year, this next-to-last Diabetes Blog Week prompt gives our community a chance to show everyone what life with diabetes really looks like. We’re giving a nod to the Diabetes 365 project by grabbing our cameras (or camera-phones) again and sharing some more D-related pictures. Some images may speak for themselves, while others might be best with a little explanation.
This year, our expanded core team at the ‘Mine have each…
Today’s Diabetes Blog Week prompt is on Fantasy Diabetes Devices — which is just up our alley, all course! We’re all in search of the “Holy Grail” tool for diabetes care, whether that’s a dream blood glucose checker, a lancer you don’t feel at all, or a super-charged insulin delivery system…
For me personally, the fantasy device at the top of my wish list would help me better handle the one thing that’s most difficult…
This past weekend, I had the privilege of speaking at the Interactive portion of the South by Southwest conference (SXSW) in Austin, TX. Launched in the mid-80s as a music festival, SXSW has grown in the last decade or so to become one of the largest festivals in the world, including all manner of social media and mobile technology. A couple of years ago, a group pulled together an unconference portion called SXSH, to focus…
Read more »
As we all know, there’s A LOT to remember when it comes to diabetes. So Timesulin, a virtual company founded in 2009 in Germany, Sweden and the UK, hopes to help patients remember whether or not they’ve taken their insulin injection.
Unlike insulin pumps, most insulin pens don’t come with a memory that you can scroll through to check whether or not you already bolused for your dinner. What to do if you’re unsure? Not taking…
If you’re an Apidra user, listen up!
Sanofi Aventis has announced that due to a technical malfunction at their plant in Frankfurt, Germany, production on all Apidra SoloSTAR insulin pens has come to a screeching halt. Sanofi has made it clear that this is an issue with the manufacturing of the pens themselves, not the insulin. Apidra insulin itself is running strong, and patients won’t have issues with previously manufactured insulin pens or any vials…